Blanchette Rockefeller Neurosciences Insitute

Quick facts

Phase 2 pipeline

• Bryostatin for Injection · Oncology
  Activates protein kinase C (PKC)

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Blanchette Rockefeller Neurosciences Insitute portfolio CI brief
• Blanchette Rockefeller Neurosciences Insitute pipeline updates RSS